Dietary caffeine intake does not affect methotrexate efficacy in patients with rheumatoid arthritis

Journal of Rheumatology

Volumn 33, Issue 7, 2006, Pages 1275-1281

  Benito Garcia, Elizabeth ^a   Heller, Jenny E ^a   Chibnik, Lori B ^a   Maher, Nancy E ^a   Matthews, Heather M ^a   Bilics, Jessica A ^a   Weinblatt, Michael E ^a   Shadick, Nancy A ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Adenosine; Aicar; Caffeine; Methotrexate; Rheumatoid arthritis

Indexed keywords

5 AMINO 4 IMIDAZOLECARBOXAMIDE RIBOSIDE; CAFFEINE; DISEASE MODIFYING ANTIRHEUMATIC DRUG; METHOTREXATE; METHYLXANTHINE;

ADULT; AGE; AGED; ARTICLE; CLINICAL TRIAL; COFFEE; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIETARY INTAKE; DISEASE ACTIVITY; DISEASE ACTIVITY SCORE; DOSE RESPONSE; DRUG EFFICACY; DRUG MEGADOSE; FEMALE; FOOD DRUG INTERACTION; GENDER; HUMAN; JOINT SWELLING; MAJOR CLINICAL STUDY; MALE; MORNING STIFFNESS; MULTIDIMENSIONAL HEALTH ASSESSMENT QUESTIONNAIRE; MULTIVARIATE ANALYSIS; PHYSICIAN GLOBAL ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; RHEUMATOID ARTHRITIS; SCORING SYSTEM; STATISTICAL SIGNIFICANCE;

ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; CAFFEINE; CENTRAL NERVOUS SYSTEM STIMULANTS; COHORT STUDIES; DIET; DRUG INTERACTIONS; FEMALE; HEALTH STATUS; HUMANS; MALE; METHOTREXATE; MIDDLE AGED; PROSPECTIVE STUDIES; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX;

EID: 33745789404     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Doan T, Massarotti E. Rheumatoid arthritis: an overview of new and emerging therapies. J Clin Pharmacol 2005;45:751-62.
2. Weinblatt ME, Coblyn JS, Fox DA, et al. Efficacy of low-dose methotrexate in rheumatoid arthritis. N Engl J Med 1985;312:818-22.
3. Montesinos MC, Yap JS, Desai A, Posadas I, McCrary CT, Cronstein BN. Reversal of the anti-inflammatory effects of methotrexate by the nonselective adenosine receptor antagonists theophylline and caffeine. Arthritis Rheum 2000;43:656-63.
4. Silke C, Murphy MS, Buckley T, Busteed S, Molloy MG, Phelan M. The effect of caffeine ingestion on the efficacy of methotrexate [abstract]. Rheumatology Oxford 2001;40 Suppl:34.
5. Nesher G, Mates M, Zevin S. Effect of caffeine consumption on efficacy of methotrexate in rheumatoid arthritis. Arthritis Rheum 2003;48:571-2.
6. Chan ES, Cronstein BN. Molecular action of methotrexate in inflammatory diseases. Arthritis Res 2002;4:266-73.
7. Baggott JE, Morgan SL, Sams WM, Linden J. Urinary adenosine and aminoimidazolecarboxamide excretion in methotrexate-treated patients with psoriasis. Arch Dermatol 1999;135:813-7.
8. Cronstein BN, Naime D, Ostad E. The anti-inflammatory mechanism of methotrexate: increased adenosine release at inflamed sites diminishes leukocyte accumulation in an in vivo model of inflammation. J Clin Invest 1993;92:2675-82.
9. Baggott JE, Vaughn WH, Hudson BB. Inhibition of 5-aminoimidazole-4- carboxamide ribotide transformylase, adenosine deaminase and 5-adenylate deaminase by polyglutamates of niethotrexate and oxidized folates and by 5-aminoimidazole-4-carboxamide riboside and ribotide. Biochem J 1986;236:193-200.
10. Cronstein BN, Kramer SB, Weissman G, Hirschhorn R. Adenosine: a physiological modulator of superoxide anion generation by human neutrophils. J Exp Med 1983;158:1160-77.
11. Cronstein BN, Kramer SB, Weissman G, Hirschhorn R. A new physiological function for adenosine: regulation of superoxide anion production. Trans Assoc Am Physicians 1983;96:384-391.
12. 1 receptors: a novel mechanism for differential regulation of Fc gamma receptor function. J Immunol 1993;151:2775-85.
13. Biaggioni I, Paul S, Puckett A, Arzubiaga C. Caffeine and theophylline as adenosine receptor antagonists in humans. Pharmacol Exp Ther 1991;258:588-93.
14. Wolfrom C, Hepp R, Hartmann R, Breithaupt H, Henze G. Pharmacokinetic study of methotrexate, folinic acid and their serum metabolites in children treated with high dose methotrexate and leucovorin rescue. Eur J Clin Pharmacol 1990;39:377-83.
15. 1 adenosine receptor and adenosine deaminase in an epithelial cell line. Mol Pharmacol 2001;59:1314-23.
16. 3 adenosine receptors in human astrocytoma cells: agonist-mediated desensitization, internalization and down-regulation. Mol Pharmacol 2002;62:1373-84.
17. Ruiz MA, Albasanz JL, Leon D, Ros M, Andres A, Martin M. Different modulation of inhibitory and stimulatory pathways mediated by adenosine after chronic in vivo agonist exposure. Brain Res 2005;1031:211-21.
18. Harvard School of Public Health Nutritional Department. Harvard.sffq.05/04.
19. Baggioni I, Davis SN. Caffeine: A cause of Insulin resistance? Diabeles Care 2002;25:399-400.
20. Suleman A, Lorenzo N. Caffeine. Emedecine; 2004 Oct 24 [cited 2006 April 9]. Available from: http://www.emedicine.com/neuro/topic666.htm
21. Fredholm BB, Ijzerman AP, Jacobson KA, Klotz KN, Linden J. Nomenclature and classification of adenosine receptors. Pharmacol Rev 2001;53:527-52.
22. 1 receptor coupling to G-proteins in brain. J Neurochem 2005;93:715-23.
23. Cronstein BN, Levin RI, Belanoff J, Weissmann G, Hirschhorn R. Adenosine: an endogenous inhibitor of neutrophil-mediated injury to endothelial cells. J Clin Invest 2001;78:760-70.
24. Bouma MG, Stad RK, van den Wildenberg FA, Buurman WA. Differential regulatory effects of adenosine on cytokine release by activated human monocytes. J Immunol 1994;153:4159-68.
25. Yamasaki E, Soma Y, Kawa Y, Mizoguchi M. Methotrexate inhibits proliferation and regulation of the expression of intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 by cultured human umbilical vein endothelial cells. Br J Dermatol 2003;149:30-8.
26. 2A receptors. Neurobiol Aging 2005;26:957-64.
27. Hornung N, Ellingsen T, Stengaard-Pedersen K, Poulsen JH. Folate, homocysteine, and cobalamin status in patients with rheumatoid arthritis treated with methotrexate, and the effect of low dose folic acid supplement. J Rheumatol 2004;31:2374-81.
28. Bamji A. Methotrexate and folic acid: what is the optimal combination? Rheumatology Oxford 2004;43:1060-1.
29. Weinblatt ME, Maier AL, Coblyn JS. Low dose leucovorin does not interfere with the efficacy of methotrexate in rheumatoid arthritis: an 8 week randomized placebo controlled trial. J Rheumatol 1993;20:950-2.
30. Naij L, DeMaster EG, Jaimes EA. Cigarette smoke-induced endothelium dysfunction: role of superoxide anion. J Hypertens 2001;19:891-7.
31. Eap CB, Bender S, Sirot EJ, et al. Nonresponse to clozapine and ultrarapid CYP1A2 activity: clinical data and analysis of CYP1A2 gene. J Clin Psychopharmacol 2004;24:214-9.
32. Johnston A, Gudjonsson JE, Sigmundsdottir H, Ludviksson BR, Valdimarsson H. The anti-inflammatory action of methotrexate is not mediated by lymphocyte apoptosis but by the suppression of activation and adhesion molecules. Clin Immunol 2005;114:154-63.
33. 2 generation, respectively. J Clin Invest 1990;85:1150-7.
34. 2A receptors in human monocytic THP-1 cells. J Immunol 2001;167:4026-32.